SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Standard BioTools Inc. (LAB) on Wednesday reported a loss of $26.9 million in its third quarter.
On a per-share basis, the South San Francisco, California-based company said it had a loss of 7 cents. Losses, adjusted for stock option expense and restructuring costs, were 5 cents per share.
The company that makes equipment to control fluids posted revenue of $45 million in the period.
Standard BioTools expects full-year revenue in the range of $170 million to $175 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on LAB at https://www.zacks.com/ap/LAB
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。